Main Industry
Biotechnology
Main Product/Service
1. CHOptimax™
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
Founded Year
2013
Unified Business No.
54170142
Status
Active
Number of Employees
20
Total Paid-in
Capital
2,140,105,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2017)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in March 2013, CHO Pharma, Inc. is dedicated to the application of innovative sugar platform technology to the development of new drugs and the treatment and detection of diseases associated with carbohydrates. Our vision is to become a leading biopharmaceutical company in the field of sugar molecular technology, and to develop new drugswith high efficacy and low side effects and accurate early detection methods to provide patients with more quality medical treatment through innovative research and development and professional technology.
